Blend Labs officer granted 2,200,000 RSUs; vesting begins 2026
Blend Labs (BLND) reported an equity grant to an officer on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Blend Labs (BLND) reported an equity grant to an officer on a Form 4. The Head of Finance and Administration received 2,200,000 restricted stock units (RSUs) on October 27, 2025, each representing one share of Class A common stock.
Per the award terms, 25% vests on August 20, 2026, with the remainder vesting in equal quarterly installments over the following three years, contingent on continued service. Following the grant, 2,200,000 derivative securities were reported as directly owned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 2,200,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of BLND Class A Common Stock.
- F2. 1/4th of the RSUs will vest on August 20, 2026, and the remaining RSUs will vest in equal quarterly increments over the following three year period, subject to the Reporting Person continuing to be a Service Provider through each such date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BLND disclose in this Form 4?
Who is the reporting person’s role at BLND?
What is the vesting schedule for the 2,200,000 RSUs at BLND?
How many securities are owned after the reported transaction?
What class of stock underlies the RSUs for BLND?
Was there a purchase price for the RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.